How much funding has InnaMed raised?

InnaMed has raised $3.2M in total funding, most recently a Convertible Note round.

Who are InnaMed's investors?

InnaMed's investors include Y Combinator Continuity Fund, DCVC (Data Collab).

Where is InnaMed headquartered?

InnaMed is headquartered in Philadelphia, Pennsylvania, United States.

What industry is InnaMed in?

InnaMed operates in Biotech, Digital Health, Healthcare.

InnaMed

Closed

At-home blood testing: measure + analyze + enhance.

Philadelphia, United States · Founded 2016 · $3.2M raised

Biotech

Digital Health

Healthcare

YC W17

Headquarters: Philadelphia, Pennsylvania
Employees: 1–10
Founded: 2016
Website: innamed.com

Total Funding: $3.2M
Last Round: $1.2M Convertible NoteMay 2021
Rounds: 2

About

InnaMed's HomeLab device and software take the hassle out of blood testing and let you access precision medical care from the comfort and privacy of your home. Healthcare providers and researchers can now receive timely clinical reports that they are accustomed to interpreting directly to their EMR, LIMS or EDC system. Trend identification and pattern matching software can guide decision making in the prescription and dosing of therapy and deep integration with the healthcare system and telehealth services allows for data driven care while also ensuring human connection.

Summary

InnaMed is a Biotech company based in Philadelphia, United States, founded in 2016. It has raised $3.2M in total across 2 rounds, most recently a $1.2M Convertible Note round in May 2021. Investors include Y Combinator Continuity Fund and DCVC (Data Collab).